Position in LLY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$21,396,632
+$4,687,172 QoQ
Shares Held
17,839
-1.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
2.30%
of 13F equity value
Holder Rank
#862
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 25%
Shared 0%
None 75%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FIRST AMERICAN TRUST, FSB holds $47,724,147 across 7 Drug Manufacturers - General names. LLY ranks #1 (44.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
17,839 | $21,396,632 | |
| 2 | ABBV |
AbbVie Inc.
|
64,713 | $16,284,378 | |
| 3 | MRK |
Merck & Co., Inc.
|
59,809 | $7,685,456 | |
| 4 | JNJ |
Johnson & Johnson
|
3,854 | $978,799 | |
| 5 | NVS |
Novartis AG
|
5,156 | $808,048 | |
| 6 | PFE |
Pfizer Inc
|
13,118 | $315,880 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,018 | $254,954 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,396,632 | 17,839 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $16,709,460 | 18,167 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $25,815,965 | 24,022 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $20,501,047 | 26,869 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $21,617,925 | 27,732 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $25,591,646 | 30,986 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $22,488,360 | 29,130 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $26,140,545 | 29,506 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $26,318,491 | 29,069 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $22,469,818 | 28,883 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $15,636,829 | 26,825 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $15,351,711 | 28,581 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $15,030,808 | 32,050 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $10,985,318 | 31,988 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $14,702,377 | 40,188 | Shares | Sole | 2023-01-25 | |
| 2022-09-30 | $12,885,497 | 39,850 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $12,791,845 | 39,453 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $11,050,731 | 38,589 | Shares | Sole | 2022-04-12 | |
| 2021-12-31 | $12,360,844 | 44,750 | Shares | Sole | 2022-01-11 | |
| 2021-09-30 | $10,194,156 | 44,121 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $9,784,437 | 42,630 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $7,926,771 | 42,430 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $4,872,722 | 28,860 | Shares | Sole | 2021-01-28 | |
| 2020-09-30 | $4,162,618 | 28,122 | Shares | Sole | 2020-10-14 | |
| 2020-06-30 | $2,060,130 | 12,548 | Shares | Sole | 2020-07-08 | |
| 2020-03-31 | $1,675,876 | 12,081 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||